You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

crizotinib

Showing 1 - 25 of 212
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Crizotinib - Usual
  • Crizotinib - Study
  • Rockville, Maryland
    Medicine Invention Design, Inc. - IORG0007849
Oct 5, 2023

NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Crizotinib - Usual
  • Crizotinib - Study
  • Rockville, Maryland
    Medicine Invention Design, Inc. - IORG0007849
Aug 15, 2023

Non Small Cell Lung Cancer Trial (TGRX-326, Crizotinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Oct 8, 2023

ALK Phosphorylation Trial in Harbin (crizotinib for rearrangement-negative, high phosphorylated ALK patients)

Completed
  • ALK Phosphorylation
  • crizotinib for rearrangement-negative, high phosphorylated ALK patients
  • Harbin, Heilongjiang, China
    Harbin Medical University Cancer Hospital
Mar 19, 2023

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Non-squamous Non-small-cell Lung Cancer, Stage IV NSCLC, ROS1 Gene Rearrangement Trial in Toronto (Crizotinib)

Recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • +4 more
  • Crizotinib
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Hematologic Cancers, Solid Tumors, Metastatic Cancer Trial in Villejuif (Crizotinib)

Active, not recruiting
  • Hematologic Cancers
  • +2 more
  • Crizotinib
  • Villejuif, Ile De France, France
    Gustave Roussy
Sep 5, 2022

Advanced Cancers Trial in Houston (Crizotinib, Dasatinib)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 29, 2022

Endometrial Cancer Recurrent Trial in Tainan (Crizotinib 250 MG)

Recruiting
  • Endometrial Cancer Recurrent
  • Crizotinib 250 MG
  • Tainan, Taiwan
    National Cheng Kung University Hospital
Jun 6, 2022

Healthy Participants Trial in New Haven (Crizotinib)

Completed
  • Healthy Participants
  • Crizotinib
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 18, 2022

ALK-positive NSCLC Trial in Shanghai (Alkotinib Capsules)

Recruiting
  • ALK-positive Non-small Cell Lung Cancer
  • Alkotinib Capsules
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Nov 28, 2022

Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))

Recruiting
  • Cancer
  • Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
  • Jinan, Shandong, China
    Shandong Provincial Qianfoshan Hospital
Jul 18, 2022

First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous

Recruiting
  • Non-small Cell Lung Cancer
  • Crizotinib
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 1, 2022

First Line Crizotinib for ALK Rearranged Non-squamous Non-small

Recruiting
  • Non-small Cell Lung Cancer
  • Crizotinib
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 1, 2022

Lung Cancer, Nonsmall Cell Trial in Aurora (Crizotinib)

Completed
Has Results
  • Lung Cancer, Nonsmall Cell
  • Crizotinib
  • Aurora, Colorado
    University of Colorado Denver
Jan 19, 2022

Castration-resistant Prostate Cancer Trial in Boston (Crizotinib, Enzalutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 5, 2022

Glioblastoma Multiforme (Grade IV) of Cerebellum Trial in L'Hospitalet de Llobregat, Barcelona, Madrid (Crizotinib)

Completed
  • Glioblastoma Multiforme (Grade IV) of Cerebellum
  • Crizotinib
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +3 more
Mar 9, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Crizotinib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Crizotinib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Feb 4, 2022

NSCLC Trial in Chang Chun (XZP-3621, Crizotinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Chang Chun, Ji Lin, China
    Jilin Province Cancer Hospital
Jan 10, 2022

Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS) Trial in United States (Crizotinib)

Active, not recruiting
  • Neurofibromatosis 2
  • Progressive Vestibular Schwannoma (VS)
  • Crizotinib
  • Birmingham, Alabama
  • +16 more
Jan 3, 2023

Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)

Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2021

ALK or ROS1-positive NSCLC Trial in China (Crizotinib)

Active, not recruiting
  • ALK or ROS1-positive NSCLC
  • Crizotinib
  • Fuzhou, Fujian, China
  • +9 more
Aug 30, 2022

NSCLC Trial in Worldwide (Repotrectinib, Crizotinib)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Augusta, Georgia
  • +40 more
Nov 29, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023